Alembic Pharmaceuticals
BSE: 533573 | NSE: APLLTD | ISIN: INE901L01018 | SECTOR: Biotechnology & DrugsOpen
594.00High
594.00Low
575.55Prev Close
590.70P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
116.02BVolume
12.12KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
533573NSE
APLLTDISIN
INE901L01018
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the active pharmaceutical ingredient (API) business and real estate business. Its pharmaceuticals business is engaged in manufacturing and marketing of fermentation and chemistry-based API. The Company is also engaged in research and development activity at Vadodara. The Company’s real estate business is engaged in the construction of residential and commercial real estate projects and project management and marketing consultancy. Its API manufacturing includes estolate, biphenyl valine oxalate, and venlafaxine. Its residential projects include Samsara, Veda, Shangri La, Urban Forest, Veda II, and KIARA. The Company is also engaged power generation through co-generation plants of approximately 11 megawatts. It has approximately four windmills of total five megawatts. The API manufacturing facility is located at Alembic Road, Vadodara, Gujarat. Its subsidiary is Alembic City Limited.
Company Officers
Chirayu Amin
Executive Chairman of the Board, Chief Executive OfficerRaj Baheti
Chief Financial Officer, Director - Finance, Executive DirectorManisha Saraf
Compliance Officer, Company SecretaryPranav Amin
Managing Director, Executive DirectorShaunak Amin
Managing Director, Executive Director